Our thanks to the British Homeopathic Association for this information poster.



Canine Osteosarcoma Trial

In January 2017, veterinary surgeon Geoff Johnson began a trial to see if homeopathy can help in the treatment of osteosarcoma in dogs.

Osteosarcoma is a very serious disease and the average survival time until euthanasia is about two months, unless amputation and chemotherapy are employed, when it is about eleven months. This trial is open to those who decide, in consultation with their vet, that amputation is not what they want for their dog.

The owners and dog will need to attend the trial centre for at least one consultation which might last up to 90 minutes. The consultations and medicine will be free.

The homeopathic remedies will be chosen specifically for the dog, based on the history and clinical signs. The dog will remain under the care of the primary vet, and if euthanasia is required, as always that decision will be taken by the owners and the primary vet. This is to ensure no additional suffering will be undergone by any dog participating in the trial.

If a dog is to be entered for the trial, the owner and vet need to complete the forms which can be downloaded from the Britsih Association of Homeopathic Veterinary Surgeons’ website – bahvs.com.
If you have any questions or wish to enter your dog for the trial, contact the centre below.

Wiveliscombe Homeopathic Veterinary Surgery
Geoff Johnson VetMB MRCVS RSHom VetFFHom PCH

Futher information on Geoff
Geoff Johnson qualified as a veterinary surgeon in 1987, and subsequently qualified in veterinary homeopathy in 1999. He is the principal of a busy homeopathic veterinary surgery in West Somerset. He lectures frequently at home and abroad. He wrote the curriculum and taught the Danish Homeopathic Veterinary Diploma, which has just graduated nine vets. He is one of the few UK vets who treats animals diagnosed with cancer using homeopathy. He lectured conventional vets on this subject at the SW and London Vet Shows in 2014.

In his Somerset practice, Geoff has gained considerable experience of treating dogs presenting with a range of canine cancers using homeopathy. He has observed some dogs entering permanent remission with the disappearance of the tumour and health restored.

Some dogs were palliated with improved vigour, lessening of clinical symptoms, and life extended beyond conventional expectations. Some dogs appeared to gain no benefit at all. He has specifically observed improvements in some dogs presenting with osteosarcoma. He has treated five such cases using solely homeopathy.

None of these dogs underwent amputation nor received chemotherapy. Two died years later of old age, one was euthanased after 22 months and two were euthanased within three months. Three of the five dogs exceeded the mean survival times of dogs which received amputation and chemotherapy, although the dogs treated received only pain relief for a short period. Two of these three dogs went into complete remission.

These anecdotal results suggest treatment from a homeopath might offer an effective adjunct to current conventional treatment.

Detractors call for homeopathic charities to loose charitable status

The Good Think Society (GTS) gave the Charity Commission an ultimatum, on the 15th September, to withdraw the charitable status of charities representing homeopathy by the end of the day or it would initiate High Court proceedings to force it to do so. This followed their initial request earlier in June.

Lawyers acting on behalf of the GTS wrote to the Charity Commission to challenge the refusal to revoke the charitable status of organisations registered as charities which advocate homeopathy – this would include Friends of the RLHIM and the British Homeopathic Association. GTS asked the Charity Commission to either revoke the registration of these charities, or commission a full review regarding organisations promoting complementary medicine that cannot show ‘public benefit based on sound scientific evidence’.

The Charity Commission have now agreed to such a review which, it is said, will be completed by July 1st, 2017.

Mark Taylor, the Chief Executive of the Society of Homeopaths has written to William Shawcross, Chair of the Charity Commission to protest. In it he rejects the GTS’s assertion that these charities should have their charitable status withdrawn.

In the letter, Taylor sets out the case for homeopathy, why these charities offer public benefit and condemns GTS for ‘the PR stunt and spectacular aversion to taking into account any evidence that undermines their own prejudices and interests.’

to read the Society of Homeopath’s letter to the Charity Commission , click here


New database of clinical trials in homeopathy

News from ECHAMP


Carstens Stiftung has launched a new database on clinical outcome research in homeopathy, in association with the Homeopathy Research Institute, called Core-HOM.

Launched in May 2014, it was created in answer to the need for a reliable and publicly available source of information in the field of clinical research in homeopathy. It is still under construction and is constantly updated, but currently consists of 1062 clinical trials, observational studies and surveys in the field of homeopathy.

Registration for and use of CORE-Hom are free of charge. The database was designed to offer researchers and the general public a solid foundation from which to assess the quality of homeopathy trials as well as the many clinical fields to which they relate. The search grid offers a way to navigate the data, offering the possibility of searching through clinical condition or clinical field, name of author and more.

In an article to introduce the new database to the public, published online in the Homeopathy Journal on 11 August 2014, the authors identify 352 of the trials referenced in the database were published in peer reviewed journals, 198 of which were randomised controlled trials. The most often used remedy was Arnica montana (n = 103). The most studied medical conditions were respiratory tract infections (n = 126) and traumatic injuries (n = 110). The article describes and explains the interface, features and content of the database.

To read the article click on the title : CORE-Hom: A powerful and exhaustive database of clinical trials in homeopathy, Clausen, Moss, Tournier, Ldtke, Albrecht; Homeopathy, 11 August 2013 or to access the database